New arthritis drug formula put to the test
NCT ID NCT03574545
Summary
This study tested if two different versions of the same drug, called ianalumab (VAY736), are equally safe and behave the same way in the body. It involved 48 people with active rheumatoid arthritis who were already on standard treatment. The main goal was to check for side effects and measure how much of the drug gets into the bloodstream over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Berlin, 10117, Germany
-
Novartis Investigative Site
Amman, 11941, Jordan
Conditions
Explore the condition pages connected to this study.